Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California. more
Time Frame | VANI | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.75% | -3.72% | -0.05% |
1-Month Return | - | -1.85% | 2.75% |
3-Month Return | 4.76% | -11.4% | 7.4% |
6-Month Return | -7.69% | -4.41% | 10.47% |
1-Year Return | 53.49% | 4.13% | 27.57% |
3-Year Return | -76.34% | 0.3% | 29.56% |
5-Year Return | -92.78% | 36.62% | 89.3% |
10-Year Return | -99.6% | 106.81% | 206.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 3.38M | 1.00K | 260.00 | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":0.01,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 2.15M | 167.00K | 345.00K | 381.00K | 357.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":7.76,"profit":true},{"date":"2021-12-31","value":16.03,"profit":true},{"date":"2022-12-31","value":17.7,"profit":true},{"date":"2023-12-31","value":16.59,"profit":true}] |
Gross Profit | 1.23M | (167.00K) | (345.00K) | (381.00K) | (357.00K) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-13.61,"profit":false},{"date":"2021-12-31","value":-28.12,"profit":false},{"date":"2022-12-31","value":-31.05,"profit":false},{"date":"2023-12-31","value":-29.1,"profit":false}] |
Gross Margin | 36.31% | (16700.00%) | (132692.31%) | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-45989.65,"profit":false},{"date":"2021-12-31","value":-365417.53,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 31.82M | 9.24M | 13.32M | 21.24M | 26.96M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":29.04,"profit":true},{"date":"2021-12-31","value":41.86,"profit":true},{"date":"2022-12-31","value":66.75,"profit":true},{"date":"2023-12-31","value":84.73,"profit":true}] |
Operating Income | (30.60M) | (9.24M) | (13.32M) | (21.24M) | (26.96M) | [{"date":"2019-12-31","value":-3059700000,"profit":false},{"date":"2020-12-31","value":-924300000,"profit":false},{"date":"2021-12-31","value":-1332300000,"profit":false},{"date":"2022-12-31","value":-2124100000,"profit":false},{"date":"2023-12-31","value":-2696500000,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (33.59M) | (9.28M) | (12.77M) | (13.89M) | (25.65M) | [{"date":"2019-12-31","value":-3359200000,"profit":false},{"date":"2020-12-31","value":-927900000,"profit":false},{"date":"2021-12-31","value":-1277300000,"profit":false},{"date":"2022-12-31","value":-1388900000,"profit":false},{"date":"2023-12-31","value":-2565200000,"profit":false}] |
Income Taxes | 362.00K | 147.70K | (641.00K) | (7.35M) | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":40.8,"profit":true},{"date":"2021-12-31","value":-177.07,"profit":false},{"date":"2022-12-31","value":-2030.94,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | - | (9.28M) | (12.77M) | (13.89M) | (26.91M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-927900000,"profit":false},{"date":"2021-12-31","value":-1277300000,"profit":false},{"date":"2022-12-31","value":-1388900000,"profit":false},{"date":"2023-12-31","value":-2691000000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (33.59M) | (9.28M) | (12.13M) | (6.54M) | (25.65M) | [{"date":"2019-12-31","value":-3359200000,"profit":false},{"date":"2020-12-31","value":-927900000,"profit":false},{"date":"2021-12-31","value":-1213200000,"profit":false},{"date":"2022-12-31","value":-653700000,"profit":false},{"date":"2023-12-31","value":-2565200000,"profit":false}] |
EPS (Diluted) | (6.54) | (2.43) | (0.24) | (0.28) | (0.50) | [{"date":"2019-12-31","value":-654,"profit":false},{"date":"2020-12-31","value":-243,"profit":false},{"date":"2021-12-31","value":-24,"profit":false},{"date":"2022-12-31","value":-28.3,"profit":false},{"date":"2023-12-31","value":-50,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
VANI | |
---|---|
Cash Ratio | 3.13 |
Current Ratio | 3.41 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
VANI | |
---|---|
ROA (LTM) | -29.29% |
ROE (LTM) | -86.10% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
VANI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.57 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.43 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
VANI | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 4.23 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Vivani Medical Inc. (VANI) share price today is $1.32
Yes, Indians can buy shares of Vivani Medical Inc. (VANI) on Vested. To buy Vivani Medical Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VANI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Vivani Medical Inc. (VANI) via the Vested app. You can start investing in Vivani Medical Inc. (VANI) with a minimum investment of $1.
You can invest in shares of Vivani Medical Inc. (VANI) via Vested in three simple steps:
The 52-week high price of Vivani Medical Inc. (VANI) is $4.8. The 52-week low price of Vivani Medical Inc. (VANI) is $0.84.
The price-to-earnings (P/E) ratio of Vivani Medical Inc. (VANI) is
The price-to-book (P/B) ratio of Vivani Medical Inc. (VANI) is 4.23
The dividend yield of Vivani Medical Inc. (VANI) is 0.00%
The market capitalization of Vivani Medical Inc. (VANI) is $77.60M
The stock symbol (or ticker) of Vivani Medical Inc. is VANI